Literature DB >> 19237078

Interferon (IFN) for malignant melanoma unmasking an autoimmune hepatitis.

Pia Lebiedz1, Christian August, Wolfram Domschke, Hartmut H-J Schmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19237078     DOI： 10.1016/j.ejim.2007.07.010

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN： 0953-6205            Impact factor:   4.487


× No keyword cloud information.
  3 in total

Review 1.  Hepatocellular carcinoma and other malignancies in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2013-01-10       Impact factor: 3.199

2.  Concurrent autoimmune hepatitis and grave's disease in hepatitis C during pegylated interferon α-2a and ribavirin therapy.

Authors:  Guru V Trikudanathan; Imad Ahmad; Jonathan L Israel
Journal:  Saudi J Gastroenterol       Date:  2011 Sep-Oct       Impact factor: 2.485

Review 3.  Safety, Tolerability, and Immunogenicity of Interferons.

Authors:  Michael G Tovey; Christophe Lallemand
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.